Connection

HANUMANTHA PULIVARTHI to Middle Aged

This is a "connection" page, showing publications HANUMANTHA PULIVARTHI has written about Middle Aged.
Connection Strength

0.205
  1. Novel t(1;3)(q21,p21) translocation in a basal cell adenocarcinoma of the parotid gland: potential association with tumorigenesis. Hum Pathol. 2016 08; 54:189-92.
    View in: PubMed
    Score: 0.015
  2. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol. 2014 Sep; 45(9):1951-6.
    View in: PubMed
    Score: 0.013
  3. Telomere stability correlates with longevity of human beings exposed to ionizing radiations. Oncol Rep. 2003 Nov-Dec; 10(6):1733-6.
    View in: PubMed
    Score: 0.013
  4. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57.
    View in: PubMed
    Score: 0.012
  5. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):114-22.
    View in: PubMed
    Score: 0.011
  6. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56.
    View in: PubMed
    Score: 0.010
  7. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31.
    View in: PubMed
    Score: 0.010
  8. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol. 2009 Nov 12; 2:47.
    View in: PubMed
    Score: 0.010
  9. Translocation (4;15)(p16;q24): a novel reciprocal translocation in a patient with BCR/ABL negative myeloproliferative syndrome progressing to blastic phase. Cancer Genet Cytogenet. 1999 May; 111(1):18-20.
    View in: PubMed
    Score: 0.009
  10. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008 Aug 15; 14(16):5181-7.
    View in: PubMed
    Score: 0.009
  11. Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue. Head Neck Pathol. 2007 Dec; 1(2):165-8.
    View in: PubMed
    Score: 0.008
  12. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression. Cytogenet Genome Res. 2007; 118(2-4):337-44.
    View in: PubMed
    Score: 0.008
  13. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81.
    View in: PubMed
    Score: 0.007
  14. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004 Aug; 40(4):355-64.
    View in: PubMed
    Score: 0.007
  15. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol. 2014 Oct; 50(10):991-9.
    View in: PubMed
    Score: 0.007
  16. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma. Blood. 2002 Apr 01; 99(7):2554-61.
    View in: PubMed
    Score: 0.006
  17. Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Haematol. 2000; 104(1):25-30.
    View in: PubMed
    Score: 0.005
  18. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene. Oncogene. 1998 Oct 01; 17(13):1717-22.
    View in: PubMed
    Score: 0.004
  19. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 1998 Sep 01; 92(5):1743-8.
    View in: PubMed
    Score: 0.004
  20. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood. 1998 Apr 15; 91(8):3007-10.
    View in: PubMed
    Score: 0.004
  21. Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change. Cancer Genet Cytogenet. 1995 Jun; 81(2):139-43.
    View in: PubMed
    Score: 0.004
  22. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol. 2004 Oct 01; 22(19):3965-72.
    View in: PubMed
    Score: 0.003
  23. Consistent chromosomal losses in head and neck squamous cell carcinoma cell lines. Genes Chromosomes Cancer. 1994 Sep; 11(1):29-39.
    View in: PubMed
    Score: 0.003
  24. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004 Aug 07; 4:45.
    View in: PubMed
    Score: 0.003
  25. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004 Jun 01; 64(11):3780-9.
    View in: PubMed
    Score: 0.003
  26. Interphase cytogenetics of gastric and esophageal adenocarcinomas. Diagn Mol Pathol. 1993 Dec; 2(4):264-8.
    View in: PubMed
    Score: 0.003
  27. Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet. 2002 Nov 14; 3:22.
    View in: PubMed
    Score: 0.003
  28. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002 Nov; 161(5):1549-56.
    View in: PubMed
    Score: 0.003
  29. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol. 2002 Aug; 161(2):365-71.
    View in: PubMed
    Score: 0.003
  30. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL. Cancer Genet Cytogenet. 2001 Oct 01; 130(1):8-13.
    View in: PubMed
    Score: 0.003
  31. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. Surgery. 2000 Dec; 128(6):888-93;discussion 893-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.